First-line first? Trends in thiazide prescribing for hypertensive seniors

PLoS Medicine

Volumn 2, Issue , 2005, Pages 0319-0324

  Morgan, Steve ^a   Bassett, Kenneth L ^a   Wright, James M ^a   Yan, Lixiang ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE AGENT; THIAZIDE DIURETIC AGENT; ANTIHYPERTENSIVE AGENT;

ACUTE HEART INFARCTION; AGE DISTRIBUTION; AGED; ARTICLE; CANADA; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; ELDERLY CARE; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRESCRIPTION; REIMBURSEMENT; SEX ROLE; AGE; CLINICAL PRACTICE; COHORT ANALYSIS; DRUG COST; ECONOMICS; SEX DIFFERENCE; STATISTICS;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BRITISH COLUMBIA; COHORT STUDIES; DRUG COSTS; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; SEX FACTORS; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 19344371332     PISSN: 15491277     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pmed.0020080     Document Type: Article

References (36)

1. IMS (2003) 2002 Canadian pharmaceutical industry review: Diagnoses and therapies. Available: http://www.imshealthcanada.com/htmen/pdf/IMSR02_T31-32. pdf. Accessed 28 January 2004.
2. Morgan SG (2004) Drug spending in Canada: Recent trends and causes. Medical Care 42: 635-642.
3. Therapeutics Initiative (2003) Therapeutics Letter 47: The Answer: Thiazides first-line for hypertension. Available: http://www.ti.ubc.ca/pages/ letter39.htm. Accessed 22 March 2004.
4. Therapeutics Initiative (1995) Drugs of choice in the treatment of hypertension (1). Available: http://www.ti.ubc.ca/pages/letter7.html. Accessed 14 Aug 2003.
5. Wright JM, Lee CH, Chambers GK (1999) Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug? CMAJ 161: 25-32.
6. Wright JM (2000) Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 1: Thiazide diuretics. CMAJ 163: 57-60.
7. Morgan SG, Barer ML, Agnew JD (2003) Whither seniors' PharmaCare: Lessons from (and for) Canada. Health Aff (Millwood) 22: 49-59.
8. Johns Hopkins University (2001) ACG Software Documentation and Users Manual. Baltimore: Johns Hopkins University Press. 294 p.
9. Maclure M, Dormuth C, Naumann T, McCormack J, Rangno R, et al. (1998) Influences of educational interventions and adverse news about calcium-channel blockers on first-line prescribing of antihypertensive drugs to elderly people in British Columbia. Lancet 352: 943-948.
10. Schneeweiss S, Soumerai SB, Maclure M, Dormuth C, Walker AM, et al. (2003) Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers. Clin Pharmacol Ther 74: 388-400.
11. Schneeweiss S, Dormuth C, Grootendorst P, Soumerai SB, Maclure M (2004) Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residents. Med Care 42: 653-660.
12. Robinson JR, Young TK, Roos LL, Gelskey DE (1997) Estimating the burden of disease. Comparing administrative data and self-reports. Med Care 35: 932-947.
13. Muhajarine N, Mustard C, Roos LL, Young TK, Gelskey DE (1997) Comparison of survey and physician claims data for detecting hypertension. J Clin Epidemiol 50: 711-718.
14. Therapeutics Initiative (1995) Drugs of choice in the treatment of hypertension (2). Available: http://www.ti.ubc.ca/pages/letter8.html. Accessed 14 August 2003.
15. Wright JM (2000) Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 3: Angiotensin-converting-enzyme inhibitors. CMAJ 163: 293-296.
16. Wright JM (2000) Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 2: Beta-blockers. CMAJ 163: 188-192.
17. SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265: 3255-3264.
18. Logan AG (1984) Report of the Canadian Hypertension Society's consensus conference on the management of mild hypertension. CMAJ 131: 1053-1057.
19. Ogilvie RI, Burgess ED, Cusson JR, Feldman RD, Leiter LA, et al. (1993) Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension. CMAJ 149: 575-584.
20. Myers MG, Carruthers SG, Leenen FH, Haynes RB (1989) Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension. CMAJ 140: 1141-1146.
21. Reeves RA, Fodor JG, Gryfe CI, Patterson C, Spence JD (1993) Report of the Canadian Hypertension Society Consensus Conference: 4. Hypertension in the elderly. CMAJ 149: 815-820.
22. Joint National Committee (1980) The 1980 report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 140: 1280-1285.
23. Joint National Committee (1984) The 1984 Report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 144: 1045-1057.
24. Joint National Committee (1988) The 1988 report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 148: 1023-1038.
25. Joint National Committee (1993) The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 153: 154-183.
26. Joint National Committee (1997) The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157: 2413-2446.
27. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289: 2560-2572.
28. McAlister FA, Levine M, Zarnke KB, Campbell N, Lewanczuk R, et al. (2001) The 2000 Canadian recommendations for the management of hypertension: Part one-therapy. Can J Cardiol 17: 543-559.
29. Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, et al. (1996) Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 276: 1886-1892.
30. (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288: 2981-2997.
31. Morgan SG, Agnew JD, Barer ML (2004) Seniors' prescription drug cost inflation and cost containment: Evidence from British Columbia. Health Policy 68: 299-307.
32. Dormuth CR, Maclure M, Bassett K, Jauca C, Whiteside C, et al. (2004) Effect of periodic letters on evidence-based drug therapy on prescribing behaviour: A randomized trial. CMAJ 171: 1057-1061.
33. (1999) Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. National Intervention Cooperative Study in Elderly Hypertensives Study Group. Hypertension 34: 1129-1133.
34. Brown MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, et al. (2000) Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 356: 366-372.
35. Schneeweiss S, Maclure M, Dormuth C, Avorn J (2002) Pharmaceutical cost containment with reference-based pricing: Time for refinements. CMAJ 167: 1250-1251.
36. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2000). Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 283: 1967-1975.